Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study-Reference-Cited by-同舟云学术

Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study

Published:2017-02-14 Issue:3 Volume:23 Page:458-465
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Hillarp A.¹,Bowyer A.²,Ezban M.³,Persson P.⁴,Kitchen S.²

Affiliation:

1. Department of Clinical Chemistry; Skåne University Hospital; Malmö Sweden

2. Coagulation Department; Sheffield Teaching Hospitals; Sheffield United Kingdom

3. Novo Nordisk A/S; Måløv Denmark

4. Novo Nordisk A/S; Søborg Denmark

Funder

Novo Nordisk

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13168/fullpdf

Reference22 articles.

1. Guidelines for the management of hemophilia;Srivastava;Haemophilia,2013

2. Half-life extended factor VIII for the treatment of hemophilia A;Tiede;J Thromb Haemost,2015

3. MASAC Recommendation Concerning Prophylaxis (Regular Administration of Clotting Factor Concentrate to Prevent Bleeding). National Hemophilia Foundation MASAC Document https://www.hemophilia.org/sites/default/files/document/files/241Prophylaxis.pdf

4. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens;Oldenburg;Blood,2015

5. Novel products for haemostasis - current status;Oldenburg;Haemophilia,2014

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life;Journal of Clinical Medicine;2024-08-23

2. The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A;Thrombosis and Haemostasis;2024-04-16

3. Variability in combinations of APTT reagent and substrate plasma for a one‐stage clotting assay to measure factor VIII products;International Journal of Laboratory Hematology;2024-03

4. A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one‐stage clotting and chromogenic substrate assays at clinical haemostasis laboratories;Haemophilia;2023-10-30

5. Hemophilia A: Diagnosis and Management;Congenital Bleeding Disorders;2023